JP Morgan Chase’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-13,500
Closed -$81.7K – 7775
2023
Q3
$81.7K Buy
+13,500
New +$111K ﹤0.01% 5606

Other funds holding ORIC

JP Morgan Chase's ORIC Position: Q3 2026 in Review

JP Morgan Chase reduced its Oric Pharmaceuticals (ORIC) stake by 83% in Q3 2026, selling an estimated $3.19M and leaving 51,674 shares worth $691K. The position accounts for ﹤0.01% of the portfolio, ranked #5005.

JP Morgan Chase first reported a position in ORIC in Q2 2020 and has held it in 26 quarters since. The position peaked at $14.7M in Q3 2025. 203 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • JP Morgan Chase held 51,674 shares of Oric Pharmaceuticals worth $691K as of Q3 2026.
  • JP Morgan Chase sold 256,594 Oric Pharmaceuticals shares in Q3 2026, an estimated $3.19M.
  • Oric Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #5005 holding.
  • JP Morgan Chase first reported a position in Oric Pharmaceuticals in Q2 2020 and has held it in 26 quarters since.
  • JP Morgan Chase's Oric Pharmaceuticals position peaked at $14.7M in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.